Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2023
Incidence of Childbirth, Pregnancy, Spontaneous Abortion, and Induced Abortion Among Women With Human Immunodeficiency Virus in a Nationwide Matched Cohort StudyFie W Paulsen, Malte M Tetens, Cecilie V Vollmond, et al.
AIDS (London, England)|November 26, 2024
Use of nonbarrier contraceptives among women with HIVFie W Paulsen, Malte M Tetens, Jan Gerstoft, et al.
Plos One|January 10, 2014
T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replicationRandi K Berg, Stine H Rahbek, Emil Kofod-Olsen, et al.
The Lancet Regional Health. Europe|January 26, 2022
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance dataMartin P Grobusch, Leisa Weld, Abraham Goorhuis, et al.
American Heart Journal|July 30, 2025
A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein-based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): Rationale and trial designMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
The Lancet. Infectious Diseases|October 10, 2022
Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional studyKristina M Angelo, Teresa Smith, Daniel Camprubí-Ferrer, et al.
American Heart Journal|May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design UpdateMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
European Heart Journal|August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trialManan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
The New England Journal of Medicine|September 1, 2025
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older AdultsMats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Pageof 8